IL2 and cancer: As a result, the Institute of Medicine’s workshop on volume-outcome relationship identified cancer treatment and non-surgical interventions as a new area of research.[27] To our knowledge, this study is the first study to report volume-outcome relationship of HD IL2 therapy.